Muffinsss Posted - 1 day ago

$RCUS a year of the same movements, tight range, appropriate level of angst with urge to sell due to lack of movement. seems like the right conditions to me.

Muffinsss Posted - 2 days ago

$RCUS It will be a good day when gilead buys them. They own 30%+, company has 1 bil cash and successful readouts. Theyd essentially be paying themselves quite a bit and shouldnt cost too much overall to aquire. Consider 5 bil purchase. thats x 3 roughly. theyd pay themselves 1.5 bil in equity and recieve left over 1 bil cash. would only cost em 2.5, affordable. speculative values of course could be a 40 billion like seagen, ahhhh x 40 that would be fun.

HarmanD Posted - 2 days ago

$RCUS Why the jump after hours?

HarmanD Posted - 2 days ago

$RCUS good dip here. Some Pharma recovering. Looks like a quick swing next few days likely. Might not be done going down but definitely a good start.

forprofit12 Posted - 6 days ago

$VKTX $MRNA $RCUS $AXSM at the end of the day, RFK is just a politician in to enrich himself and keep getting reelected. For that he needs big donors and phama has huge pockets and influence. You think he will just come in and start banning things? If you think so you are out of touch of reality.

TheGunnerAB Posted - 6 days ago

$SWTX $RCUS BNTML !

IceJuice Posted - 1 week ago

$RCUS shocker, how quick all the gains from last week went away … same 💩 different week

techNICKaltrader Posted - 1 week ago

$RCUS added. Patient swing.

NVDAMillionaire Posted - 1 week ago

$RCUS Arcus Biosciences (RCUS): Pioneering Immuno-Oncology Breakthroughs Amidst Challenges https://beyondspx.com/article/arcus-biosciences-rcus-pioneering-immuno-oncology-breakthroughs-amidst-challenges

Shlobby Posted - 1 week ago

$RCUS over 19.30 I'm in

TheTechnicalTrader Posted - 1 week ago

$RCUS what a sleeper…. But don’t sleep on this! $GILD 30% ownership

shukra_123 Posted - 1 week ago

$RCUS arcus results are superior than Merck keyvibe-008 https://x.com/suyogcancer/status/1854948245828780501?s=46

shukra_123 Posted - 2 weeks ago

$RCUS https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.com%2Fv3%2F__https%3A%2F%2Fe.endpointsnews.com%2Ft%2Ft-l-sttgkl-jukjluxit-a%2F__%3B!!BxdPRWaV7w!0dBFk6XIblK9I3eib6caezvqJ-4dZ_qLJEEpIvjLPWiGmCa_Sp3Owr2jiYprTZhDAHxqiVIdX6JItWIj%24&data=05%7C02%7Cmlamani%40arcusbio.com%7C9941808e599141e592b708dcff49ea2a%7C1ad4c8f944ec48709515b42d64d49a4e%7C0%7C0%7C638665940247578580%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=QXIoEAbX7tFLWtp4QZHYhpnuVtqOWv6hGg2Rtk%2F85io%3D&reserved=0

DonCorleone77 Posted - 2 weeks ago

$RCUS Arcus Biosciences reports Q3 EPS ($1.00), consensus ($1.06) Reports Q3 revenue $48M, consensus $37.56M. "Through the course of this year, we have presented multiple compelling datasets at medical conferences that we believe have de-risked several programs and support potential best-in-class profiles for our molecules, including our HIF-2a inhibitor casdatifan in ccRCC and our Fc-silent anti-TIGIT antibody domvanalimab in lung and upper gastrointestinal cancers," said Terry Rosen, Ph.D., chief executive officer of Arcus. "Meanwhile, in addition to our rapidly approaching first Phase 3 readout for domvanalimab in gastric cancer, we are aggressively pursuing our development plan for casdatifan, including in the IO-naive ccRCC setting in collaboration with AstraZeneca, and in the post-IO setting with the initiation of our Phase 3 PEAK-1 study in the first half of next year."

shukra_123 Posted - 2 weeks ago

$RCUS https://www.oncologypipeline.com/apexonco/sitc-2024-arcus-springs-tigit-surprise

DefenseMania Posted - 2 weeks ago

$RCUS yes GILD bought 33% of the RCUS FLOAT earlier this year @$21.00 share Bonus coming imo

Muffinsss Posted - 2 weeks ago

$RCUS im waiting for the day gilead buys them. what do they own now 30% or so?

oswan Posted - 2 weeks ago

$RCUS $XBI https://investors.arcusbio.com/investors-and-media/press-releases/press-release-details/2024/Arcus-Biosciences-Announces-that-Domvanalimab-Plus-Zimberelimab-Improved-Overall-Survival-in-ARC-10-a-Randomized-Study-in-Patients-with-PD-L1-High-Non-Small-Cell-Lung-Cancer/default.aspx

eriklarsen Posted - 2 weeks ago

$RCUS We should have new ARC 10 TIGIT data at SITC soon.

DefenseMania Posted - 2 weeks ago

$RCUS next week will be good 🚀🚀🚀save this post !!! $GILD $AZN $PFE $MRK

forprofit12 Posted - 10/31/24

$RCUS what stupid manipulation especially after good results

DefenseMania Posted - 10/30/24

$RCUS drops to $15.50 I buy another 25k shares

kuzeylee Posted - 10/30/24

$RCUS Ladies and gentlemen, our flight is starting soon. Make your last purchases immediately. We will see you at $40.

briefingcom Posted - 10/30/24

$RCUS: Arcus Biosciences to present new data for Anti-TIGIT domvanalimab plus zimberelimab at the society for Immunotherapy of Cancer Annual Meeting https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241030090506RCUS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

TheTradeXchange Posted - 10/30/24

$RCUS - Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting

TheTradeXchange Posted - 10/30/24

$RCUS Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting

forprofit12 Posted - 10/25/24

$RCUS so the 20 price target set a few days ago was signal to other crooks to short it at 20. These corrupt MF manipulate stocks right in front of our eyes.

shukra_123 Posted - 10/24/24

$RCUS https://biotechstrategyblog.com/2024/10/arcus-takes-aim-at-belzutifan-in-the-hif-2%CE%B1-arena.html/

Shlobby Posted - 10/24/24

$Rcus interesting on here decent r/r for a flyer

shukra_123 Posted - 10/24/24

$RCUS